Brief: Nurix Therapeutics Reports Fourth Quarter, Fiscal Year 2022 Financial Results
09/02/2023 22:07
Feb 9 (Reuters) - Nurix Therapeutics Inc NRIX.O :
* NURIX THERAPEUTICS REPORTS FOURTH QUARTER AND FISCAL YEAR
2022
FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.87
* Q4 EARNINGS PER SHARE VIEW $-0.79 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7S0QR
Further company coverage: NRIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nurix Therapeutics
See all newsNurix Therapeutics Q3 swings to profit on Roche collaboration
Brief: Nurix Extends Gilead Collaboration For Oncology Program
Commercialize Potential Best-In-Class Btk Degrader Bexobrutideg Across Malignant Hematology, Immunology And Neurology
Nurix Therapeutics Q2 revenue falls sharply, net loss widens; strikes up to $2.3 bln collab with Roche
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis